AMNESTEEM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amnesteem, and what generic alternatives are available?
Amnesteem is a drug marketed by Mylan Pharms Inc and is included in one NDA.
The generic ingredient in AMNESTEEM is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amnesteem
A generic version of AMNESTEEM was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMNESTEEM?
- What are the global sales for AMNESTEEM?
- What is Average Wholesale Price for AMNESTEEM?
Summary for AMNESTEEM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 23 |
| Patent Applications: | 7,499 |
| Drug Prices: | Drug price information for AMNESTEEM |
| Drug Sales Revenues: | Drug sales revenues for AMNESTEEM |
| DailyMed Link: | AMNESTEEM at DailyMed |
Recent Clinical Trials for AMNESTEEM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| Dr. Reddy's Laboratories Limited | Phase 1 |
| National Cancer Institute (NCI) | N/A |
Pharmacology for AMNESTEEM
| Drug Class | Retinoid |
US Patents and Regulatory Information for AMNESTEEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AMNESTEEM | isotretinoin | CAPSULE;ORAL | 075945-001 | Nov 8, 2002 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Pharms Inc | AMNESTEEM | isotretinoin | CAPSULE;ORAL | 075945-002 | Nov 8, 2002 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Pharms Inc | AMNESTEEM | isotretinoin | CAPSULE;ORAL | 075945-003 | Nov 8, 2002 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
